<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Abnormal nuclear megakaryocytic staining for phospho-STAT5 (pSTAT5) correlates with JAK2 V617F mutational status in non-<z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, a proportion of <z:mp ids='MP_0002169'>wild-type</z:mp> JAK2 non-<z:hpo ids='HP_0005506'>chronic myelogenous leukemia</z:hpo> <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> cases also demonstrate this abnormal pSTAT5 expression pattern </plain></SENT>
<SENT sid="2" pm="."><plain>We report a patient with a JAK2 V617F-negative myeloproliferative/<z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> who had abnormal megakaryocytic pSTAT5 expression and a MPL W515L mutation </plain></SENT>
<SENT sid="3" pm="."><plain>The patient was a 71-year-old man with <z:hpo ids='HP_0001903'>anemia</z:hpo> and <z:e sem="disease" ids="C0836924" disease_type="Disease or Syndrome" abbrv="">thrombocythemia</z:e> on laboratory examination </plain></SENT>
<SENT sid="4" pm="."><plain>His peripheral blood smear demonstrated occasional dysplastic neutrophils </plain></SENT>
<SENT sid="5" pm="."><plain>Bone marrow biopsy revealed hypercellular marrow with features consistent with myeloproliferative/<z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Immunohistochemistry for pSTAT5 showed abnormal nuclear megakaryocyte positivity </plain></SENT>
<SENT sid="7" pm="."><plain>Cytogenetic analysis revealed a <z:mpath ids='MPATH_458'>normal</z:mpath> karyotype, fluorescence in situ hybridization for BCR-ABL was negative, and JAK2 genotyping demonstrated <z:mp ids='MP_0002169'>wild-type</z:mp> JAK2 </plain></SENT>
<SENT sid="8" pm="."><plain>However, MPL genotyping showed a MPL W515L mutation </plain></SENT>
<SENT sid="9" pm="."><plain>Abnormal nuclear megakaryocytic staining for pSTAT5 expression, previously associated with the JAK2 V617F mutation, is also associated with MPL W515L, likely reflecting activation of the JAK-STAT signaling pathway </plain></SENT>
</text></document>